Andrew D. Kosar

Array ( [id] => 865213 [patent_doc_number] => 07368576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents' [patent_app_type] => utility [patent_app_number] => 11/481349 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22628 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368576.pdf [firstpage_image] =>[orig_patent_app_number] => 11481349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484380 [patent_doc_number] => 07902155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Therapeutic methods using cyclosporine components' [patent_app_type] => utility [patent_app_number] => 11/479741 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902155.pdf [firstpage_image] =>[orig_patent_app_number] => 11479741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835324 [patent_doc_number] => 20060247155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Methods for alleviating deleterious effects of 3-deoxyglucosone' [patent_app_type] => utility [patent_app_number] => 11/478497 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16886 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247155.pdf [firstpage_image] =>[orig_patent_app_number] => 11478497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602874 [patent_doc_number] => 20060293219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'METHODS OF TREATING DIABETES MELLITUS' [patent_app_type] => utility [patent_app_number] => 11/424295 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18678 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293219.pdf [firstpage_image] =>[orig_patent_app_number] => 11424295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057587 [patent_doc_number] => 20070060509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Endoparasiticidal compositions for topical application' [patent_app_type] => utility [patent_app_number] => 11/451676 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6165 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060509.pdf [firstpage_image] =>[orig_patent_app_number] => 11451676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515380 [patent_doc_number] => 07932228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/451142 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5157 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932228.pdf [firstpage_image] =>[orig_patent_app_number] => 11451142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185100 [patent_doc_number] => 07648959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Methods and compositions for the treatment of diseases of the eye' [patent_app_type] => utility [patent_app_number] => 11/448001 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8501 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648959.pdf [firstpage_image] =>[orig_patent_app_number] => 11448001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754031 [patent_doc_number] => 20060223180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Methods to mobilize progenitor/stem cells' [patent_app_type] => utility [patent_app_number] => 11/446390 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12385 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223180.pdf [firstpage_image] =>[orig_patent_app_number] => 11446390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786436 [patent_doc_number] => 20060205659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Fumaric Acid Amides' [patent_app_type] => utility [patent_app_number] => 11/421083 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2923 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205659.pdf [firstpage_image] =>[orig_patent_app_number] => 11421083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242851 [patent_doc_number] => 20070021346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'N-terminally modified GLP-1 receptor modulators\n' [patent_app_type] => utility [patent_app_number] => 11/442017 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 45566 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021346.pdf [firstpage_image] =>[orig_patent_app_number] => 11442017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 526709 [patent_doc_number] => 07183279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/440727 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8938 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183279.pdf [firstpage_image] =>[orig_patent_app_number] => 11440727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155112 [patent_doc_number] => 20070037995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'A Substantially Cell Membrane Impermeable Compound And Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/419644 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29468 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037995.pdf [firstpage_image] =>[orig_patent_app_number] => 11419644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155113 [patent_doc_number] => 20070037996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'A Substantially Cell Membrane Impermeable Compound And Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/419651 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29449 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037996.pdf [firstpage_image] =>[orig_patent_app_number] => 11419651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82187 [patent_doc_number] => 07745574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Compounds that regulate apoptosis' [patent_app_type] => utility [patent_app_number] => 11/433783 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 28440 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745574.pdf [firstpage_image] =>[orig_patent_app_number] => 11433783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683490 [patent_doc_number] => 20060199760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Methods for the therapeutic use of cyclosporine components' [patent_app_type] => utility [patent_app_number] => 11/429050 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4846 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199760.pdf [firstpage_image] =>[orig_patent_app_number] => 11429050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705666 [patent_doc_number] => 20060194714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Novel depsipeptides and process for preparing same' [patent_app_type] => utility [patent_app_number] => 11/414762 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20151 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194714.pdf [firstpage_image] =>[orig_patent_app_number] => 11414762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299892 [patent_doc_number] => 07538091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Intracellular delivery of biological effectors' [patent_app_type] => utility [patent_app_number] => 11/408393 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11901 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538091.pdf [firstpage_image] =>[orig_patent_app_number] => 11408393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619983 [patent_doc_number] => 20060189517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/405331 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12120 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189517.pdf [firstpage_image] =>[orig_patent_app_number] => 11405331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678335 [patent_doc_number] => 20060183691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Anti-hypertensive molecules and process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/398374 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9756 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183691.pdf [firstpage_image] =>[orig_patent_app_number] => 11398374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322741 [patent_doc_number] => 07517974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Factor VII or VIIa-like molecules' [patent_app_type] => utility [patent_app_number] => 11/396314 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29158 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517974.pdf [firstpage_image] =>[orig_patent_app_number] => 11396314 [rel_patent_id] =>[rel_patent_doc_number] =>)